Patent details

EP2501799 Title: PRODUCTION OF GLYCOPROTEINS WITH LOW N-GLYCOLYLNEURAMINIC ACID (NEU5GC) CONTENT

Basic Information

Publication number:
EP2501799
PCT Application Number:
EP2010067793
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107818882
PCT Publication Number:
WO2011061275
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PRODUCTION OF GLYCOPROTEINS WITH LOW N-GLYCOLYLNEURAMINIC ACID (NEU5GC) CONTENT
French Title of Invention:
Production de glycoprotéines dotées d'une faible teneur en acide N-glycolylneuraminique (Neu5Gc)
German Title of Invention:
Herstellung von Glykoproteinen mit niedrigem N-Glykolylneuraminsäure-Gehalt (Neu5Gc-Gehalt)
SPC Number:

Dates

Filing date:
19/11/2010
Grant date:
24/01/2018
EP Publication Date:
26/09/2012
PCT Publication Date:
26/05/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/01/2018
EP B1 Publication Date:
24/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/11/2018
Expiration date:
19/11/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/01/2018
 
 

Name:
LEK Pharmaceuticals d.d.
Address:
Verovskova 57, 1526 Ljubljana, Slovenia (SI)

Inventor

Name:
FICKO TRCEK, Tanja
Address:
Slovenia (SI)

Priority

Priority Number:
09176631
Priority Date:
20/11/2009
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
C07K 14/47; C12N 5/00; C12P 21/00;

Publication

European Patent Bulletin

1

Issue number:
201804
Publication date:
24/01/2018
Description:
Grant (B1)

2

Issue number:
201848
Publication date:
28/11/2018
Description:
Opposition procedure started

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2019 Outgoing Correspondence 1